scispace - formally typeset
R

Ramesh Rathi

Researcher at Harvard University

Publications -  21
Citations -  1531

Ramesh Rathi is an academic researcher from Harvard University. The author has contributed to research in topics: Polyethylene glycol & Polymer. The author has an hindex of 10, co-authored 20 publications receiving 1485 citations. Previous affiliations of Ramesh Rathi include University of Utah.

Papers
More filters
Journal ArticleDOI

Biodegradable block copolymers for delivery of proteins and water-insoluble drugs

TL;DR: ReGel's inherent ability to solubilize (400 to >2000-fold) and stabilize poorly soluble and sensitive drugs, including proteins is a substantial benefit and the gel provided excellent control of the release of paclitaxel for approximately 50 days.
Patent

Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties

TL;DR: A block copolymer made of a major amount of hydrophobic poly(lactide-co-glycolide) copolymers and a minor amount of a hydrophilic polyethylene glycol polymer B-block, having an overall average molecular weight of between about 3100 and 4500, possesses reverse thermal gelation properties.
Journal ArticleDOI

Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres.

TL;DR: The sustained drug release profile and cellular internalization results suggest that nanospheres loaded with paclitaxel may potentially be used as an endocytizable, local sustained drug delivery system for the prevention of restenosis.
Journal ArticleDOI

EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video).

TL;DR: The EUS-guided injection of OncoGel into the pancreas of the pig provided high and sustained localized concentrations of paclitaxel, and this technique is a potential minimally invasive local treatment option for unresectable pancreatic tumors.
Journal ArticleDOI

Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel

TL;DR: The results suggest that the local delivery of antiproliferative agents using a thermosensitive, injectable biodegradable copolymer (ReGel) for sustained delivery is a promising strategy to inhibit neointimal hyperplasia of arteriovenous hemodialysis grafts.